Back
Veracyte, Inc. 10K Form
Buy
86
VCYT
Veracyte, Inc.
Last Price:
$47.41
Seasonality Move:
1.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VCYT News And Ratings
See the #1 stock for the next 7 days that we like better than VCYT
VCYT Financial Statistics
Sales & Book Value
| Annual Sales: | $445.8M |
|---|---|
| Cash Flow: | $42M |
| Price / Cash Flow: | 38.66 |
| Annual Sales: | $15.91 |
| Price / Book: | 3 |
Profitability
| EPS (TTM): | 0.37960 |
|---|---|
| Net Income (TTM): | $30.3M |
| Gross Margin: | $289.5M |
| Return on Equity: | 2.52% |
| Return on Assets: | 2.28% |
Veracyte, Inc. Earnings Forecast
Key Veracyte, Inc. Financial Ratios
-
The Gross Profit Margin over the past 14 years for VCYT is 64.95%.
-
The Selling, General & Administrative Expenses for VCYT have been equal to 46.22% of Gross Profit Margin.
-
The Research & Development expenses have been 15.26% of Revenue.
-
The Interest Expense is 0.01% of Operating Income.
-
The Net Earning history of VCYT is 5.41% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 8 years.
Veracyte, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VCYT |
| CUSIP: | 92337F |
| Website: | veracyte.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 6.23 |
| Quick Ratio: | 5.74 |
Price-to-Earnings
| Trailing P/E Ratio: | 154.63 |
|---|---|
| Forward P/E Ratio: | 29.79 |
VCYT Technical Analysis vs Fundamental Analysis
Buy
86
Veracyte, Inc. (VCYT)
is a Buy
Is Veracyte, Inc. a Buy or a Sell?
-
Veracyte, Inc. stock is rated a BuyThe current Veracyte, Inc. [VCYT] share price is $47.75. The Score for VCYT is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.